SAN DIEGO, Sept. 4, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the Rodman and Renshaw Annual Global Investment Conference on Wednesday, September 9, 2009 at 4:30 p.m. Eastern time. The conference is being held at The Palace Hotel in New York City.
